SYENF Stock | News | Quote | Stock Forum | Saturday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Syngenta AG SYENF Company Overview 

Stock Message Board http://investorshangout.com/search?q=SYENF&am...mp;yt1=Go!

Last Updated: Saturday, October 12, 2013 12:20:47 PM

Syngenta AG SYENF Current Price and Quotes
Last Price 396.50
Previous Close 394.20 Open 396.50
Daily Range 396.50 - 396.50 52wk Range 442.00 - 363.50
Volume 5 Dividend N/A
Average Vol (3m) 505 Yield N/A
Syngenta AG SYENF
Company Information

Schwarzwaldallee 215
Basel 4058
Switzerland

Website: http://www.syngenta.com
Phone: 41-61-323-1111

Syngenta AG SYENF
Not Available

Syngenta AG SYENF
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2012 20-F
CIK 0001123661
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2870 - Agricultural Chemicals
Incorporated In: Switzerland
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Michael Pragnell CEO
John Atkin COO
Richard Steiblin CFO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Syngenta AG SYENF
SYENF Security Details Other Company Securities

Share Structure

Market Value1 $36,926,045,000 a/o Oct 11, 2013
Shares Outstanding 93,130,000 a/o Jun 30, 2012
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

SYNN - SIX Swiss Exchange - Qualified
Short Selling Data

Short Interest 108,941 (12.1%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Syngenta AG SYENF Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 14,202,000 13,268,000 11,641,000 10,992,000
Cost of Revenue 7,218,000 6,786,000 5,900,000 5,572,000
Gross Profit 6,984,000 6,482,000 5,741,000 5,420,000
Operating Expenses

Research and Development 1,253,000 1,191,000 1,081,000 952,000
Sales, General and Admin. 3,181,000 3,009,000 2,708,000 2,519,000
Non-Recurring Items 233,000 307,000 178,000 130,000
Other - - - -
Operating Income 2,292,000 2,051,000 1,793,000 1,819,000
Income From Continuing Operations

Add'l Income/Expense Items (30,000) 63,000 50,000 41,000
Earnings Before Interest and Tax 2,294,000 2,053,000 1,849,000 1,857,000
Interest Expense 142,000 152,000 172,000 163,000
Earnings Before Tax 2,152,000 1,901,000 1,677,000 1,694,000
Income Tax 277,000 301,000 275,000 283,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary 7,000 15,000 25,000 (3,000)
Net Income Cont. Operations 1,882,000 1,615,000 1,427,000 1,408,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,875,000 1,600,000 1,402,000 1,411,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,875,000 1,600,000 1,402,000 1,411,000

Syngenta AG SYENF Recent News

Sept 30, 2013 Senior Management Changes, Esteemed Recognitions, Earnings Conferences, Promising Partnerships, and New Leadership Academy - Research Report on CF, Mosaic, Monsanto, Ashland, and Syngenta
Jul 24, 2013 Syngenta launches second trading line on SIX Swiss Exchange for the repurchase of registered shares
Jul 22, 2013 OTC Daily Alert Stock Watch


SYENF Syngenta AG Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SYENF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SYENF/quote
Stock Chart http://www.otcmarkets.com/stock/SYENF/chart
Company Info http://www.otcmarkets.com/stock/SYENF/company-info
Recent News http://www.otcmarkets.com/stock/SYENF/news
Financials http://www.otcmarkets.com/stock/SYENF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SYENF/filings
Short Sales http://www.otcmarkets.com/stock/SYENF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SYENF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SYENF/research
Summary http://finance.yahoo.com/q?s=SYENF
Historical Prices http://finance.yahoo.com/q/hp?s=SYENF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SYENF
Basic Chart http://finance.yahoo.com/q/bc?s=SYENF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SYENF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SYENF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SYENF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SYENF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SYENF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SYENF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SYENF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SYENF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SYENF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SYENF
Balance Sheet http://finance.yahoo.com/q/bs?s=SYENF
Cash Flow http://finance.yahoo.com/q/cf?s=SYENF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SYENF
Market Watch http://www.marketwatch.com/investing/stock/SYENF
Bloomberg http://www.bloomberg.com/quote/SYENF:US
Morningstar http://quotes.morningstar.com/stock/s?t=SYENF
Bussinessweek http://investing.businessweek.com/research/st...cker=SYENF
Barchart http://www.barchart.com/quotes/stocks/SYENF
OTC Short Report http://otcshortreport.com/index.php?index=SYENF
Investopedia http://www.investopedia.com/markets/stocks/SYENF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 198

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 163

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 410

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Globant's 2025 Q1 Revenue Growth and Strategic Focus

Updated Category News Views 873

Globant's Remarkable Financial Performance for Q1 2025 Globant (NYSE: GLOB), a leader in technology-enabled business transformation, has reported a strong performance for the first quarter of 2025. The company achieved revenues of $611.1 million, marking a 7.0% increase compared to the same period last year. This notable growth reflects Globant's commitment to leveraging...

Continue Reading
Transforming Rehabilitation: The Future of Medical Exoskeletons

Updated Category News Views 329

Explosive Growth in the Medical Exoskeleton Market The global medical exoskeleton market is experiencing remarkable growth, projected to reach a value increase of USD 2.87 billion during the upcoming period from 2024 to 2028. A crucial driving force behind this surge is the rising number of spinal cord injury (SCI) cases, coupled with advancements in artificial...

Continue Reading
Exclusive Elks Hoop Shoot Champions Honored at Hall of Fame

Updated Category News Views 167

Celebrating Youth Basketball Talent The spirit of perseverance and hard work was palpable as the finest youth free-throw shooters gathered at Wintrust Arena, illustrating their dedication to the game. Recently, the Elks Hoop Shoot competition showcased young athletes' skills and determination as they vied for national titles in three age groups for both boys and girls....

Continue Reading
Key Insights for Cepton, Inc. Investors Regarding Legal Actions

Updated Category News Views 190

Understanding Your Legal Rights as a Cepton, Inc. Investor Cepton, Inc. (NASDAQ: CPTN) has recently come under scrutiny, attracting the attention of investors concerned about potential securities fraud. As such, it is crucial for shareholders to be informed about their rights and options as they navigate these turbulent waters. Recent developments suggest that investors...

Continue Reading
Teamsters at Seattle Airport Vote to Strike Against Swissport

Updated Category News Views 283

Teamsters at Seattle Airport Take Bold Action In a significant move toward ensuring safe and fair labor practices, air fuelers at Seattle-Tacoma International Airport have voted unanimously to authorize a strike against Swissport, a leading provider of ground services in the aviation industry. With over 150 workers represented by Teamsters Local 174, this decision stems...

Continue Reading